tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Reni Benjamin, 193 are a BUY (85.78%), 30 are a HOLD (13.33%), 2 are a SELL (0.89%).
Analyst Reni Benjamin, currently employed at JMP, carries an average stock price target met ratio of 43.81% that have a potential upside of 54.39% achieved within 174 days.
Reni Benjamin’s has documented 410 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BCYC, Bicycle Therapeutics Ltd at 31-Oct-2025.
Analyst best performing recommendations are on SANA (SANA BIOTECHNOLOGY).
The best stock recommendation documented was for PRLD (PRELUDE THERAPEUTICS ) at 8/18/2025. The price target of $3 was fulfilled within 77 days with a profit of $2.06 (219.15%) receiving and performance score of 28.46.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 24-Nov-2025
$10
$2.92 (41.24%)
$11
1 months 15 days ago
(24-Nov-2025)
0/5 (0%)
$3.68 (58.23%)
Buy
Since 20-Apr-2021
$12
$4.92 (69.49%)
$10
2 months 8 days ago
(31-Oct-2025)
1/14 (7.14%)
$3.93 (48.70%)
174
Hold
Since 12-Sep-2022
$13
$5.92 (83.62%)
$17
4 months 27 days ago
(12-Aug-2025)
0/8 (0%)
$5.78 (80.06%)
Buy
Since 11-Jun-2020
$48
4 months 28 days ago
(11-Aug-2025)
3/8 (37.5%)
$25.45 (112.86%)
192
Hold
Since 07-Aug-2024
$14
$6.92 (97.74%)
$17
8 months 6 days ago
(02-May-2025)
1/9 (11.11%)
$4.7 (50.54%)
12
Which stock is Reni Benjamin is most bullish on?
Which stock is Reni Benjamin is most reserved on?
What Year was the first public recommendation made by Reni Benjamin?
